Revance Therapeutics, Inc. $5,368,090 Glaukos Corp $4,453,641 Si-Bone, Inc. $0 Revance Therapeutics, Inc. $5,368,090 Glaukos Corp $4,453,641 Si-Bone, Inc. $0